Analysis of different innovative formulations of curcumin for improved relative oral bioavailability

Completed

• Conditions: utritional supplement; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN17535884
• Lead Sponsor: Wacker Chemie AG (Germany)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-12-29
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

1. Healthy individuals
2. Age: 20-35 years
3. Males and females
4. Participants agreed to sign an informed consent form
5. Participants must be able to perform required testing

Exclusion Criteria

1. Consuming any curcumin-containing supplements or foods for two weeks prior to testing
2. History of any of the following: hyperacidity, gastric/duodenal ulcers, gastrointestinal problems, gallbladder issues
3. Use of any blood thinners/anti-thrombotic agents or NSAIDS
4. Prior use of blood sugar-lowering agents, H2 blockers, or proton pump inhibitors
5. Known allergies to soy
6. Diabetics
7. Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified